Lipomedics' Unattributed - II Round

Lipomedics raised a round of funding on June 09, 2016.

LipoMedics develops personalized paclitaxel therapy based on its proprietary Therapeutic Drug Monitoring (TDM) device and its platform for delivery of water insoluble drugs including paclitaxel. The c…

Articles about Lipomedics' Unattributed - II Round: